Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Doesn't look good

Sometimes I think CPMV is worse off than when it was PTSC.

If private company Moasic's plan was to buy a public or merge with a public in order to go big time or just to simply get cash to further their research it hasn't worked.

If a reverse split is still on the table at this point we are crawling towards it.

And if a reverse split happens at this point will it help or work? I'm think no.

Especially at this point you can't tell me they're sitting on something. I don't buy it.

MAYBE there will be something in the March quarter end but I doubt it.

Share
New Message
Please login to post a reply